Neurology

Experimental therapy slows zika replication and prevents microcephaly in mice




An international group of researchers have discovered that inhibiting AHR (aryl hydrocarbon receptor), a protein with roles in regulating immunity, stem cell maintenance and cellular differentiation, enables the immune system to combat replication of zika virus in the organism far more effectively.

Source link

Related posts

Effects of Posterior Fossa Decompression in Hunt and Hess Grade V Subarachnoid Hemorrhage Patients after Endovascular Trapping of Ruptured Vertebral Artery Dissecting Aneurysms.

Newsemia

Screen-Free Travel Activities That Kids Will Love!

Newsemia

Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World